New evidence for the use of DCB

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Anchorperson: R. Byrne
Spokesperson: M. A. Rosli
SHOW MORE

Summary

This session reviews emerging evidence supporting the use of drug-coated balloons (DCB) in complex PCI. It covers data from recent trials such as SELUTION De Novo, studies on vascular healing, restenosis patterns, long-term outcomes compared to DES, and optimal side branch treatment in bifurcation lesions.

Presentations available when logged in:

  • Sirolimus eluting balloon in complex PCI: evidence from the SELUTION De Novo trial
  • Vascular healing at bifurcation after side-branch drug-coated vs. conventional balloon: OCT study
  • Angiographic patterns of restenosis following DCB angioplasty for de novo coronary lesions
  • Long-term outcomes of DCB angioplasty vs. DES implantation for small vessel coronary artery disease
  • Coronary bifurcation lesions side branch optimal treatment study: the BILBO multicentre study